132 related articles for article (PubMed ID: 34491470)
1. Combination of conserved recombinant proteins (NP & 3M2e) formulated with Alum protected BALB/c mice against influenza A/PR8/H1N1 virus challenge.
Forqani M; Hosseini SM; Farahmand B; Saleh M; Shokouhi H; Torabi A; Fotouhi F
Biotechnol Lett; 2021 Nov; 43(11):2137-2147. PubMed ID: 34491470
[TBL] [Abstract][Full Text] [Related]
2. Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses.
Kwak C; Nguyen QT; Kim J; Kim TH; Poo H
J Microbiol Biotechnol; 2021 Feb; 31(2):304-316. PubMed ID: 33263336
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
Shokouhi H; Farahmand B; Ghaemi A; Mazaheri V; Fotouhi F
Virus Res; 2018 Jun; 251():40-46. PubMed ID: 29730305
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge.
Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P
Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215
[TBL] [Abstract][Full Text] [Related]
5. Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.
Mytle N; Leyrer S; Inglefield JR; Harris AM; Hickey TE; Minang J; Lu H; Ma Z; Andersen H; Grubaugh ND; Guina T; Skiadopoulos MH; Lacy MJ
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578289
[TBL] [Abstract][Full Text] [Related]
6. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
Wang W; Huang B; Wang X; Tan W; Ruan L
Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
[TBL] [Abstract][Full Text] [Related]
7. Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.
Zhang J; Fan HY; Zhang Z; Zhang J; Zhang J; Huang JN; Ye Y; Liao M
Vaccine; 2016 Jan; 34(5):622-629. PubMed ID: 26724200
[TBL] [Abstract][Full Text] [Related]
8. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
Huang B; Wang W; Li R; Wang X; Jiang T; Qi X; Gao Y; Tan W; Ruan L
Virol J; 2012 Dec; 9():322. PubMed ID: 23272943
[TBL] [Abstract][Full Text] [Related]
9. A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.
Hervé PL; Raliou M; Bourdieu C; Dubuquoy C; Petit-Camurdan A; Bertho N; Eléouët JF; Chevalier C; Riffault S
J Virol; 2014 Jan; 88(1):325-38. PubMed ID: 24155388
[TBL] [Abstract][Full Text] [Related]
10. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
11. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
Kammoun H; Roux X; Raze D; Debrie AS; De Filette M; Ysenbaert T; Mielcarek N; Saelens X; Fiers W; Locht C
PLoS One; 2013; 8(3):e59198. PubMed ID: 23555631
[TBL] [Abstract][Full Text] [Related]
13. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.
Calzas C; Mao M; Turpaud M; Viboud Q; Mettier J; Figueroa T; Bessière P; Mangin A; Sedano L; Hervé PL; Volmer R; Ducatez MF; Bourgault S; Archambault D; Le Goffic R; Chevalier C
Front Immunol; 2021; 12():772550. PubMed ID: 34868036
[TBL] [Abstract][Full Text] [Related]
15. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
[TBL] [Abstract][Full Text] [Related]
16. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Immune Response of Recombinant H1N1 Hemagglutinin with MF59 Adjuvant in Animal Model as a Novel Alternative to the Influenza Vaccine.
Rashedi N; Taghizadeh M; Mohamadynejad P; Mahdavi M; Jalalirad R
Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):497-508. PubMed ID: 33463117
[TBL] [Abstract][Full Text] [Related]
18. An approach to the influenza chimeric subunit vaccine (3M2e-HA2-NP) provides efficient protection against lethal virus challenge.
Saleh M; Nowroozi J; Farahmand B; Fotouhi F
Biotechnol Lett; 2020 Jul; 42(7):1147-1159. PubMed ID: 32152828
[TBL] [Abstract][Full Text] [Related]
19. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).
Mu X; Hu K; Shen M; Kong N; Fu C; Yan W; Wei A
J Virol Methods; 2016 Feb; 228():84-90. PubMed ID: 26615805
[TBL] [Abstract][Full Text] [Related]
20. Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.
Alvarez P; Zylberman V; Ghersi G; Boado L; Palacios C; Goldbaum F; Mattion N
Vaccine; 2013 Jan; 31(5):806-12. PubMed ID: 23246552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]